European Journal of Clinical Pharmacology

Papers
(The H4-Index of European Journal of Clinical Pharmacology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
How to make the best of NLRP3 inhibitors in patients with COVID-19?90
Might chronic spontaneous urticaria develop after SARS-CoV-2 vaccinations?46
A Study Of the effect of Sex on drug dosing, concentrations, and pharmacogenomics in the Montreal Heart Institute Hospital Cohort (SOS-PGx): methodology and research progress34
Medication adherence among persons with coronary heart disease and associations with blood pressure and low-density-lipoprotein-cholesterol33
Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia33
Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study30
Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study27
Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany25
Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study25
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease23
Incidence and risk factors of drug-induced kidney injury in children: a systematic review and meta-analysis23
Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers22
Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data22
Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia22
Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service—a cross-sectional study of patients in a Canadian Health Region21
Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus20
The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis20
Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials20
Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans19
0.059835910797119